Published Nov 21 2009 by PharmaBiz
Pfizer inks pact with DNDi to fight human African trypanosomiasis, visceral leishmaniasis & Chagas disease
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world....
Share this
There are no more reports on this story yet.